VinDr-Mammo

FDA 510(k) K233108 · Vinbigdata Joint Stock Company

Substantially Equivalent

510(k) numberK233108

Submission

Device name
VinDr-Mammo
Applicant
Vinbigdata Joint Stock Company
Ha Noi, VN
Received
September 27, 2023
Decision date
May 23, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QFM – Radiological Computer-Assisted Prioritization Software For Lesions
Device class
Class II (moderate risk)
Regulation
21 CFR 892.2080
Specialty
Radiology

Radiological computer-assisted prioritization software for lesions is an image processing device intended to aid in prioritization and triage of time sensitive patient detection and diagnosis based on the analysis of medical images acquired from radiological signal acquisition systems. The device identifies or prioritizes time sensitive imaging for review by prespecified clinical users based on…

Other 510(k)s with product code QFM

510(k)DeviceApplicantDecision
K253751CXRDetectAIQFM · Traditional Neurocareai, Inc. (Dba Savelife.Ai)07/08/2026SE
K252954MammoSightAIQFM · Traditional Neurocareai, Inc. (Dba Savelife.Ai)05/04/2026SE
K252482CogNet AI-MT+QFM · Traditional Medcognetics, Inc.12/11/2025SE
K250831Annalise EnterpriseQFM · Special Annalise-Ai04/23/2025SE
K243808Rayvolve PTX-PEQFM · Traditional AZmed03/21/2025SE
K243548BriefCase-TriageQFM · Special Aidoc Medical , Ltd.12/11/2024SE
K241439VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link TriageQFM · Traditional Vuno, Inc.11/15/2024SE
K240612Cina-VcfQFM · Traditional Avicenna.Ai05/31/2024SE
K232410SmartChestQFM · Traditional Milvue05/10/2024SE
K231871Radify TriageQFM · Abbreviated Envisionit Deepai, Ltd.01/17/2024SE

Questions and answers

When was VinDr-Mammo cleared by the FDA?

VinDr-Mammo (K233108) received a 510(k) decision of Substantially Equivalent on May 23, 2024, 239 days after the submission was received.

What is the product code of K233108?

The FDA product code is QFM – Radiological Computer-Assisted Prioritization Software For Lesions, a Class II (moderate risk) device regulated under 21 CFR 892.2080.